Nowadays, HIV+ patients have an expected lifespan that is only slightly shorter than healthy
individuals. For this reason, along with the fact that infection can be acquired at a relatively …

Carbapenem-resistant Gram-negative bacteria (CR-GNB) represent an increasing hazard in
healthcare settings. A central question concerning the treatment of invasive infections …

Abstract Background Before April 2022, monkeypox virus infection in humans was seldom
reported outside African regions where it is endemic. Currently, cases are occurring …

Background No therapy is approved for COVID-19 pneumonia. The aim of this study was to
assess the role of tocilizumab in reducing the risk of invasive mechanical ventilation and …

The authors investigated the effect of highly active antiretroviral therapy (HAART) on the
onset and outcome of progressive multifocal leukoencephalopathy (PML) in a group of 43 …

The immune system of patients infected by SARS-CoV-2 is severely impaired. Detailed
investigation of T cells and cytokine production in patients affected by COVID-19 pneumonia …

Background People living with HIV have accounted for 38–50% of those affected in the 2022
multicountry mpox outbreak. Most reported cases were in people who had high CD4 cell …

Background Two commercial blood assays for the diagnosis of latent tuberculosis infection—
T-SPOT. TB and QuantiFERON-TB Gold—have been separately compared with the …

Weeks and months after the onset of acute COVID-19, people continue to suffer. Paul
Garner, a professor of epidemiology at Liverpool School of Tropical Medicine, UK, wrote on …

To extend the understanding of host genetic determinants of HIV-1 control, we performed a
genome-wide association study in a cohort of 2,554 infected Caucasian subjects. The study …